Tag: sanofi

April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
February 26, 2019

Senate Finance Committee Blasts Pharma CEOs on Drug Prices

This was the largest panel of pharmaceutical executives "in decades" to appear before a congressional committee.
December 24, 2018

Pharma Outlook 2019: Drug Pricing Dialogue Continues

During this challenging time in healthcare news, our pharma outlook aims to help investors steer through the industry.
December 19, 2018

Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq

Sanofi announced that it will be transferring the listing of its American Depositary Shares (ADS) from the New York Stock...
December 3, 2018

4 Gene Therapy Companies to Watch

What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
November 29, 2018

FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes

Lexicon Pharmaceuticals (Nasdaq:LXRX), today announced that the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) plans...
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?